Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-32P is a human pseudogene classified as a sequence-related copy of the U1 small nuclear RNA genes. Pseudogenes like RNU1-32P do not encode a functional RNA product and are generally considered non-functional remnants of gene duplication or retrotransposition. It is not a canonical functional RNA, but instead represents a non-functional, sequence-related copy of the RNU1-1 gene. No established biological function, disease association, or pharmacological relevance is attributed to RNU1-32P. There is no evidence or report that RNU1-32P plays a direct role in disease, cell biology, drug response, or patient selection. The name RNU1-32P is correct for the pseudogene but is not a recognized target in the sense of receptors, enzymes, transporters, or regulatory RNAs used in biomedical applications. Pursuing this entity as a therapeutic target is not appropriate. This entry should be flagged as non-actionable and likely incorrect for drug discovery or target validation contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 32, pseudogene (RNU1-32P).